Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing

Anthony P. Belanger, John F. Byrne, Justin M. Paolino, Timothy R DeGrado

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The bubble point test is the de facto standard for postproduction filter membrane integrity test in the radiopharmaceutical community. However, the bubble point test depends on a subjective visual assessment of bubbling rate that can be obscured by significant diffusive gas flows below the manufacturer's prescribed bubble point. To provide a more objective means to assess filter membrane integrity, this study evaluates the pressure-hold test as an alternative to the bubble point test. In our application of the pressure-hold test, the nonsterile side of the sterilizing filter is pressurized to 85% of the predetermined bubble point with nitrogen, the filter system is closed off from the pressurizing gas and the pressure is monitored over a prescribed time interval. The drop in pressure, which has a known relationship with diffusive gas flow, is used as a quantitative measure of membrane integrity. Characterization of the gas flow vs. pressure relationship of each filter/solution combination provides an objective and quantitative means for defining a critical value of pressure drop over which the membrane is indicated to be nonintegral. The method is applied to sterilizing filter integrity testing associated with the commonly produced radiopharmaceuticals, [18F]FDG and [11C]PIB. The method is shown to be robust, practical and amenable to automation in radiopharmaceutical manufacturing environments (e.g., hot cells).

Original languageEnglish (US)
Pages (from-to)955-959
Number of pages5
JournalNuclear Medicine and Biology
Volume36
Issue number8
DOIs
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Radiopharmaceuticals
Pressure
Membranes
Gases
Automation
Fluorodeoxyglucose F18
Nitrogen

Keywords

  • Filter membrane integrity
  • Pressure-hold test
  • Radiopharmaceutical

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing. / Belanger, Anthony P.; Byrne, John F.; Paolino, Justin M.; DeGrado, Timothy R.

In: Nuclear Medicine and Biology, Vol. 36, No. 8, 11.2009, p. 955-959.

Research output: Contribution to journalArticle

Belanger, Anthony P. ; Byrne, John F. ; Paolino, Justin M. ; DeGrado, Timothy R. / Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing. In: Nuclear Medicine and Biology. 2009 ; Vol. 36, No. 8. pp. 955-959.
@article{41430e5da8164afd96e68f6a8f928158,
title = "Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing",
abstract = "The bubble point test is the de facto standard for postproduction filter membrane integrity test in the radiopharmaceutical community. However, the bubble point test depends on a subjective visual assessment of bubbling rate that can be obscured by significant diffusive gas flows below the manufacturer's prescribed bubble point. To provide a more objective means to assess filter membrane integrity, this study evaluates the pressure-hold test as an alternative to the bubble point test. In our application of the pressure-hold test, the nonsterile side of the sterilizing filter is pressurized to 85{\%} of the predetermined bubble point with nitrogen, the filter system is closed off from the pressurizing gas and the pressure is monitored over a prescribed time interval. The drop in pressure, which has a known relationship with diffusive gas flow, is used as a quantitative measure of membrane integrity. Characterization of the gas flow vs. pressure relationship of each filter/solution combination provides an objective and quantitative means for defining a critical value of pressure drop over which the membrane is indicated to be nonintegral. The method is applied to sterilizing filter integrity testing associated with the commonly produced radiopharmaceuticals, [18F]FDG and [11C]PIB. The method is shown to be robust, practical and amenable to automation in radiopharmaceutical manufacturing environments (e.g., hot cells).",
keywords = "Filter membrane integrity, Pressure-hold test, Radiopharmaceutical",
author = "Belanger, {Anthony P.} and Byrne, {John F.} and Paolino, {Justin M.} and DeGrado, {Timothy R}",
year = "2009",
month = "11",
doi = "10.1016/j.nucmedbio.2009.07.008",
language = "English (US)",
volume = "36",
pages = "955--959",
journal = "International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Use of pressure-hold test for sterilizing filter membrane integrity in radiopharmaceutical manufacturing

AU - Belanger, Anthony P.

AU - Byrne, John F.

AU - Paolino, Justin M.

AU - DeGrado, Timothy R

PY - 2009/11

Y1 - 2009/11

N2 - The bubble point test is the de facto standard for postproduction filter membrane integrity test in the radiopharmaceutical community. However, the bubble point test depends on a subjective visual assessment of bubbling rate that can be obscured by significant diffusive gas flows below the manufacturer's prescribed bubble point. To provide a more objective means to assess filter membrane integrity, this study evaluates the pressure-hold test as an alternative to the bubble point test. In our application of the pressure-hold test, the nonsterile side of the sterilizing filter is pressurized to 85% of the predetermined bubble point with nitrogen, the filter system is closed off from the pressurizing gas and the pressure is monitored over a prescribed time interval. The drop in pressure, which has a known relationship with diffusive gas flow, is used as a quantitative measure of membrane integrity. Characterization of the gas flow vs. pressure relationship of each filter/solution combination provides an objective and quantitative means for defining a critical value of pressure drop over which the membrane is indicated to be nonintegral. The method is applied to sterilizing filter integrity testing associated with the commonly produced radiopharmaceuticals, [18F]FDG and [11C]PIB. The method is shown to be robust, practical and amenable to automation in radiopharmaceutical manufacturing environments (e.g., hot cells).

AB - The bubble point test is the de facto standard for postproduction filter membrane integrity test in the radiopharmaceutical community. However, the bubble point test depends on a subjective visual assessment of bubbling rate that can be obscured by significant diffusive gas flows below the manufacturer's prescribed bubble point. To provide a more objective means to assess filter membrane integrity, this study evaluates the pressure-hold test as an alternative to the bubble point test. In our application of the pressure-hold test, the nonsterile side of the sterilizing filter is pressurized to 85% of the predetermined bubble point with nitrogen, the filter system is closed off from the pressurizing gas and the pressure is monitored over a prescribed time interval. The drop in pressure, which has a known relationship with diffusive gas flow, is used as a quantitative measure of membrane integrity. Characterization of the gas flow vs. pressure relationship of each filter/solution combination provides an objective and quantitative means for defining a critical value of pressure drop over which the membrane is indicated to be nonintegral. The method is applied to sterilizing filter integrity testing associated with the commonly produced radiopharmaceuticals, [18F]FDG and [11C]PIB. The method is shown to be robust, practical and amenable to automation in radiopharmaceutical manufacturing environments (e.g., hot cells).

KW - Filter membrane integrity

KW - Pressure-hold test

KW - Radiopharmaceutical

UR - http://www.scopus.com/inward/record.url?scp=70350234477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350234477&partnerID=8YFLogxK

U2 - 10.1016/j.nucmedbio.2009.07.008

DO - 10.1016/j.nucmedbio.2009.07.008

M3 - Article

C2 - 19875052

AN - SCOPUS:70350234477

VL - 36

SP - 955

EP - 959

JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology

SN - 0969-8051

IS - 8

ER -